NKT-Like (CD3+CD56+) Cells in Chronic Myeloid Leukemia Patients Treated With Tyrosine Kinase Inhibitors. This evidence concerns the gene NCAM1 and chronic myelogenous leukemia, BCR-ABL1 positive.